October 13, 2003 MEDIA ADVISORY: Lance Armstrong and Tour of Hope
A news conference featuring Tour de France five-time champion Lance Armstrong and his oncologist Larry Einhorn, M.D., who developed the regimen to successfully treat testicular cancer, will be in the Collins/Fuson Interview Room, Conseco Fieldhouse, at 10 a.m. Thursday, Oct. 16. Access the news conference through the Media/Employee Entrance on Delaware Street. A photo ID or media credentials are necessary for sign-in at the Fieldhouse. Media are strongly encouraged to arrive early. Tickets are only required for admission for the general public. Following the news conference, media are invited to attend the event at the Fieldhouse where Armstrong will speak to the general public and more than 350 testicular cancer survivors treated at the IU Cancer Center. He will be accompanied by several members of the Tour of Hope cycling team. Armstrong was successfully treated in 1996 at IU Cancer Center for advanced testicular cancer. Also speaking at the main event, which will be from 10:45 a.m. to noon, will be Dr. Einhorn; former IUCC patient John Cleland, a Zionsville high school science teacher who was among the first to be cured with the new regimen; and Elliott Sigal, M.D., Ph.D., senior vice president of Global Clinical and Pharmaceutical Development at Bristol-Myers Squibb. The Tour of Hope, sponsored by Bristol-Myers Squibb, was created to raise awareness of the importance of cancer research, specifically clinical trials. The Tour of Hope cyclists will relay ride 3,000 miles from Los Angeles to Washington, D.C., Oct. 11-18. They will be joined along the route by Armstrong. Following the public event, a special information session on advances in testicular cancer treatments will be conducted for the survivors and family members. Additional information on the Tour of Hope can be found at The Indianapolis event is sponsored by the IU Cancer Center, IU School of Medicine, the Pacers Sports & Entertainment, Indiana University Hospital - Clarian Health Partners and Bristol-Myers Squibb. |
INDIANA UNIVERSITY A STATEWIDE Phone Fax |
||||||||||
|
|
|||||||||||